DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors (Q41604739)

5 October 2017

1 reference

title

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors (English)

1 reference

5 October 2017

0 references

0 references

Ramsay AJ

1

1 reference

PubMed ID

9315482

5 October 2017

Leong KH

series ordinal

2

1 reference

PubMed ID

9315482

5 October 2017

Ramshaw IA

series ordinal

3

1 reference

5 October 2017

1 August 1997

1 reference

Immunology & Cell Biology

5 October 2017

1 reference

5 October 2017

75

1 reference

5 October 2017

4

1 reference

5 October 2017

382-388

1 reference

Direct gene transfer into mouse muscle in vivo

5 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

The role of interleukin-6 in mucosal IgA antibody responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

DNA immunization against experimental genital herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Immune response to neonatal genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Recombinant vaccinia viruses and the development of immunization strategies using influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

A case for cytokines as effector molecules in the resolution of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Functional role of type I and type II interferons in antiviral defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Simian immunodeficiency virus DNA vaccine trial in macaques.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Immune responses to plasmid DNA encoding the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

DNA vaccination against persistent viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Protection against rotavirus infections by DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

DNA immunization confers protection against murine cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.60

7 January 2021

Identifiers

DOI

10.1038/ICB.1997.60

1 reference

5 October 2017

1 reference

PubMed ID

9315482